MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Saved in:
| Title: | MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. |
|---|---|
| Authors: | Mithoefer MC; Medical University of South Carolina, Charleston, SC, USA., Feduccia AA; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA. alli@mapsbcorp.com., Jerome L; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA., Mithoefer A; Private Practice, Charleston, SC, USA., Wagner M; Medical University of South Carolina, Charleston, SC, USA., Walsh Z; University of British Columbia-Okanagan, Kelowna, BC, Canada., Hamilton S; Stanford School of Medicine, Stanford University, Stanford, CA, USA., Yazar-Klosinski B; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA., Emerson A; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA., Doblin R; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA. |
| Source: | Psychopharmacology [Psychopharmacology (Berl)] 2019 Sep; Vol. 236 (9), pp. 2735-2745. Date of Electronic Publication: 2019 May 07. |
| Publication Type: | Journal Article; Retracted Publication; Clinical Trial Protocol |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
